ReviewPharmacological reports : PR2024
A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment.
Mansour TobaiqyPubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it